90-Day readmission after radical prostatectomy—a prospective comparison between robot-assisted and open surgery

References

• Tewari A, Sooriakumaran P, Bloch DA, et al. Positive surgical margin and perioperative complication rates of primary surgical treatments for prostate cancer: a systematic review and meta-analysis comparing retropubic, laparoscopic, and robotic prostatectomy. Eur Urol. 2012;62:1–15.
   PubMed Web of Science ®Google Scholar
• Ficarra V, Minervini A, Antonelli A, et al. A multicentre matched-pair analysis comparing robot-assisted versus open partial nephrectomy. BJU Int. 2014;113:936–941.
   PubMed Web of Science ®Google Scholar
• De Carlo F, Celestino F, Verri C, et al. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: surgical, oncological, and functional outcomes: a systematic review. Urol Int. 2014;93:373–383.
   PubMed Web of Science ®Google Scholar
• Carlsson S, Nilsson AE, Schumacher MC, et al. Surgery-related complications in 1253 robot-assisted and 485 Open Retropubic Radical Prostatectomies at the Karolinska University Hospital, Sweden. Urology 2009; S0090–4295:02762–02769.
   Google Scholar
• Haglind E, Carlsson S, Stranne J, et al. Urinary incontinence and erectile dysfunction after robotic versus open radical prostatectomy: a prospective, controlled, nonrandomised trial. Eur Urol. 2015;68:216–225.
   PubMed Web of Science ®Google Scholar
• Thorsteinsdottir T, Stranne J, Carlsson S, et al. LAPPRO: a prospective multicentre comparative study of robot-assisted laparoscopic and retropubic radical prostatectomy for prostate cancer. Scand J Urol Nephrol. 2011;45:102–112.
   PubMed Web of Science ®Google Scholar
• Sobin LH, Compton CC. T.N.M. seventh edition: what's new, what's changed: communication from the International Union Against Cancer and the American Joint Committee on Cancer. Cancer 2010;116:5336–5339.
   PubMed Web of Science ®Google Scholar
• Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159:702–706.
   PubMed Web of Science ®Google Scholar
• Wallerstedt A, Tyritzis SI, Thorsteinsdottir T, et al. Short-term results after robot-assisted laparoscopic radical prostatectomy compared to open radical prostatectomy. Eur Urol. 2015;67:660–670.
   PubMed Web of Science ®Google Scholar
• White IR, Royston P, Wood AM. Multiple imputation using chained equations: Issues and guidance for practice. Stat Med. 2011;30:377–399.
   PubMed Web of Science ®Google Scholar
• Wallerstedt A, Tyritzis SI, Thorsteinsdottir T, et al. Short-term results after robot-assisted laparoscopic radical prostatectomy compared to open radical prostatectomy. Eur Urol. 2015;67:660–670.
   Web of Science ®Google Scholar
• Leow JJ, Chang SL, Meyer CP, et al. Robot-assisted versus open radical prostatectomy: A contemporary analysis of an all-payer discharge database. Eur Urol. 2016;70:837–845.
   PubMedGoogle Scholar
• Yaxley JW, Coughlin GD, Chambers SK, et al. Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study. Lancet 2016;388:1057–1066.
   PubMed Web of Science ®Google Scholar
• Trinh QD, Sammon J, Sun M, et al. Perioperative outcomes of robot-assisted radical prostatectomy compared with open radical prostatectomy: results from the nationwide inpatient sample. Eur Urol. 2012;61:679–685.
   PubMed Web of Science ®Google Scholar
• Alemozaffar M, Sanda M, Yecies D, et al. Benchmarks for operative outcomes of robotic and open radical prostatectomy: results from the Health Professionals Follow-up Study. Eur Urol. 2015;67:432–438.
   PubMed Web of Science ®Google Scholar
• Kim JK, Kim HS, Park J, et al. Perioperative blood transfusion as a significant predictor of biochemical recurrence and survival after radical prostatectomy in patients with prostate cancer. PLoS One. 2016;11:e0154918.
   PubMed Web of Science ®Google Scholar
• Lloyd JC, Banez LL, Aronson WJ, et al. Estimated blood loss as a predictor of PSA recurrence after radical prostatectomy: results from the SEARCH database. BJU Int. 2010;105:347–351.
   PubMed Web of Science ®Google Scholar
• Oefelein MG, Colangelo LA, Rademaker AW, et al. Intraoperative blood loss and prognosis in prostate cancer patients undergoing radical retropubic prostatectomy. J Urol. 1995;154:442–447.
   PubMed Web of Science ®Google Scholar
• Paul R, Schmid R, Busch R, et al. Influence of blood transfusions during radical retropubic prostatectomy on disease outcome. Urology 2006;67:137–141.
   PubMed Web of Science ®Google Scholar
• Ford BS, Sharma S, Rezaishiraz H, et al. Effect of perioperative blood transfusion on prostate cancer recurrence. Urol Oncol. 2008;26:364–367.
   PubMed Web of Science ®Google Scholar
• Gallina A, Briganti A, Chun FK, et al. Effect of autologous blood transfusion on the rate of biochemical recurrence after radical prostatectomy. BJU Int. 2007;100:1249–1253.
   PubMed Web of Science ®Google Scholar
• Ness PM, Walsh PC, Zahurak M, et al. Prostate cancer recurrence in radical surgery patients receiving autologous or homologous blood. Transfusion 1992;32:31–36.
   PubMed Web of Science ®Google Scholar
• Boehm K, Beyer B, Tennstedt P, et al. No impact of blood transfusion on oncological outcome after radical prostatectomy in patients with prostate cancer. World J Urol. 2015;33:801–806.
   PubMed Web of Science ®Google Scholar
• Keskin MS, Argun OB, Obek C, et al. The incidence and sequela of lymphocele formation after robot-assisted extended pelvic lymph node dissection. BJU Int. 2016;118:127–131.
   PubMed Web of Science ®Google Scholar
• Orvieto MA, Coelho RF, Chauhan S, et al. Incidence of lymphoceles after robot-assisted pelvic lymph node dissection. BJU International. 2011;108:1185–1190.
   Google Scholar
• Lapidus L, Borretzen J, Fahlen M, et al. Home treatment of deep vein thrombosis. An out-patient treatment model with once-daily injection of low-molecular-weight heparin (tinzaparin) in 555 patients. Pathophysiol Haemo T. 2002;32:59–66.
   PubMedGoogle Scholar
• Backman K, Carlsson P, Kentson M, et al. Deep venous thrombosis: a new task for primary health care. A randomised economic study of outpatient and inpatient treatment. Scand J Prim Health Care. 2004;22:44–49.
   PubMed Web of Science ®Google Scholar
• Van Hemelrijck M, Garmo H, Holmberg L, et al. Thromboembolic events following surgery for prostate cancer. Eur Urol. 2013;63:354–363.
   PubMed Web of Science ®Google Scholar
• Friethriksson JO, Holmberg E, Adolfsson J, et al. Rehospitalization after radical prostatectomy in a nationwide, population based study. J Urol. 2014;192:112–119.
   PubMed Web of Science ®Google Scholar
• Steinsvik EA, Fossa SD, Axcrona K, et al. Do perceptions of adverse events differ between patients and physicians? Findings from a randomized, controlled trial of radical treatment for prostate cancer. J Urol. 2010;184:525–531.
   PubMed Web of Science ®Google Scholar
• Litwin MS, Lubeck DP, Henning JM, et al. Differences in urologist and patient assessments of health related quality of life in men with prostate cancer: results of the CaPSURE database. J Urol. 1998;159:1988–1992.
   PubMed Web of Science ®Google Scholar
• Mansson A, Henningsohn L, Steineck G, et al. Neutral third party versus treating institution for evaluating quality of life after radical cystectomy. Eur Urol. 2004;46:195–199.
   PubMed Web of Science ®Google Scholar